NO-platform
NO platform allows you to synthesize original hybrid molecules consisting of pharmaceutically active compounds (API), prostaglandins (PG) and nitric oxide donors (NO-donors)
Main News
* Gurus successfully completed preclinical trials of asthma treatment drug * Magazine Kommersant published an article about promising multifunctional drug candidates of Gurus BioPharm * Gurus raises $0.7M for preclinical trials of a drug for asthma

19.10.2015  Magazine Kommersant published an article about promising multifunctional drug candidates of Gurus BioPharm

Magazine Kommersant published an article about promising multifunctional drug candidates of Gurus BioPharm.
You can read the article here http://www.kommersant.ru/doc/2835942